UniProtKB/Swiss-Prot P35613: Variant p.Gly269Val

Basigin
Gene: BSG
Feedback?

Variant information Variant position:

269 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Valine (V) at position 269 (G269V, p.Gly269Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Loss of interaction with P.falciparum RH5. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs1803203 [ dbSNP | Ensembl ]

Sequence information Variant position:

269 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

385 The length of the canonical sequence.
Location on the sequence:

PVTDWAWYKITDSEDKALMN G SESRFFVSSSQGRSELHIEN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PVTDWAWYKITDSE-DKALMNGSE--SRFFVSSSQGRSELHIEN

Mouse                         PITDWFWFKTSDTGEEEAITNSTEANGKYVVVSTPEKSQLT

Rat                           PVDEWVWFKTSDTG-DQTISNGTEANSKYVIISTPELSELI

Rabbit                        FVTAWVWYKVADSG-DQVIQNGSQ--SRFFISHSEAQSELH

Chicken                       PVDHWAWYK---SG-QTVPLESSA--GIYNISRTGNKTELR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	22 – 385	Basigin
Topological domain	138 – 323	Extracellular
Domain	221 – 315	Ig-like V-type
Glycosylation	268 – 268	N-linked (GlcNAc...) asparagine
Disulfide bond	242 – 301
Mutagenesis	268 – 268	N -> D. No effect on the interaction with P.falciparum RH5; when associated with D-160 and D-302.

Literature citations
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.
Crosnier C.; Bustamante L.Y.; Bartholdson S.J.; Bei A.K.; Theron M.; Uchikawa M.; Mboup S.; Ndir O.; Kwiatkowski D.P.; Duraisingh M.T.; Rayner J.C.; Wright G.J.;
Nature 480:534-537(2011)
Cited for: FUNCTION (ISOFORMS 1 AND 2) (MICROBIAL INFECTION); INTERACTION WITH P.FALCIPARUM RH5 (ISOFORMS 1 AND 2) (MICROBIAL INFECTION); GLYCOSYLATION; VARIANTS ASN-152; LEU-176; PRO-206; LYS-208 AND VAL-269; MUTAGENESIS OF ASN-160; ASN-268 AND ASN-302;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.